Role of epigenomics in bone and cartilage disease

JBJ van Meurs, CG Boer… - Journal of Bone and …, 2019 - academic.oup.com
Phenotypic variation in skeletal traits and diseases is the product of genetic and
environmental factors. Epigenetic mechanisms include information‐containing factors, other …

BCL6 as a therapeutic target for lymphoma

RJ Leeman-Neill, G Bhagat - Expert opinion on therapeutic targets, 2018 - Taylor & Francis
Introduction: B cell lymphoma 6 (BCL6) is a transcriptional repressor critical for the
development and maintenance of germinal centers (GCs), which are required for generation …

BCL6 is regulated by the MAPK/ELK1 axis and promotes KRAS-driven lung cancer

K Li, Y Liu, Y Ding, Z Zhang, J Feng… - The Journal of …, 2022 - Am Soc Clin Investig
Mutational activation of KRAS is a common oncogenic event in lung cancer, yet effective
therapies are still lacking. Here, we identify B cell lymphoma 6 (BCL6) as a lynchpin in …

TET‐catalyzed oxidation of intragenic 5‐methylcytosine regulates CTCF‐dependent alternative splicing

RJ Marina, D Sturgill, MA Bailly, M Thenoz… - The EMBO …, 2016 - embopress.org
Intragenic 5‐methylcytosine and CTCF mediate opposing effects on pre‐mRNA splicing:
CTCF promotes inclusion of weak upstream exons through RNA polymerase II pausing …

A network model to describe the terminal differentiation of B cells

A Méndez, L Mendoza - PLoS computational biology, 2016 - journals.plos.org
Terminal differentiation of B cells is an essential process for the humoral immune response
in vertebrates and is achieved by the concerted action of several transcription factors in …

[HTML][HTML] Anti-malarial humoral immunity: the long and short of it

KJ Rogers, R Vijay, NS Butler - Microbes and infection, 2021 - Elsevier
Humoral immunity is critical for limiting Plasmodium parasite infections and the severity of
malaria. Naturally acquired immunity against malaria occurs inefficiently and protection is …

[HTML][HTML] CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis

Q Lai, Q Li, C He, Y Fang, S Lin, J Cai, J Ding… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
CTCF is overexpressed in several cancers and plays crucial roles in regulating
aggressiveness, but little is known about whether CTCF drives colorectal cancer …

Epigenetic control of B cell development and B-cell-related immune disorders

Y Bao, X Cao - Clinical reviews in allergy & immunology, 2016 - Springer
B lymphocytes are generally recognized as the essential component of humoral immunity
and also a regulator of innate immunity. The development of B cells is precisely regulated by …

Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells

MG Cortiguera, L García-Gaipo, SD Wagner, J León… - Scientific Reports, 2019 - nature.com
Multiple genetic aberrations in the regulation of BCL6, including in acetyltransferase genes,
occur in clinically aggressive B-cell lymphomas and lead to higher expression levels and …

Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCF

X Cheng, A Joseph, V Castro, A Chen-Liaw… - PLoS …, 2021 - journals.plos.org
Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus that causes an aggressive T-cell
malignancy and a variety of inflammatory conditions. The integrated provirus includes a …